Jakafi 20 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XTQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,090
Award facts
- Contract value 100% obligated
- $12,089.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 20 mg tablets (60-count units). The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Park Ridge, Illinois. This delivery order was executed without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that serves as a critical supplier in the federal pharmaceutical supply chain. This delivery order is issued under the company's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC vehicle enables the DoD to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables supporting military health facilities worldwide. Jakafi (ruxolitinib) is a prescription medication used in the treatment of certain blood disorders and inflammatory conditions, and this order fulfills specific pharmaceutical supply requirements for Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DX25F6XTQ?
SPE2DX25F6XTQ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 18, 2025.
How much is contract SPE2DX25F6XTQ worth?
The government has obligated $12,090 on SPE2DX25F6XTQ.
Is contract SPE2DX25F6XTQ an order under another contract?
Yes. SPE2DX25F6XTQ is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTQ competed?
The extent of competition for SPE2DX25F6XTQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award